Advanced Care Management in Patients With Advanced Heart Failure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03526627|
Recruitment Status : Recruiting
First Posted : May 16, 2018
Last Update Posted : May 29, 2019
|Condition or disease|
|Advanced Heart Failure|
this study is to observe the trajectory of the advanced care management on patients with advanced heart failure and follow the difference between the actual medical treatment accepted by patients on 2years later and the preference of the patient and their families.
the advance care management in this study is mean the patients who know about the preference of medical treatment, communication, and prognosis of illness. we also measure the sense of coherence, self-efficacy and their quality of life to compare their relationship of the advanced care management.
|Study Type :||Observational|
|Estimated Enrollment :||227 participants|
|Official Title:||Advanced Care Management in Patients With Advanced Heart Failure|
|Actual Study Start Date :||January 4, 2018|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||December 31, 2020|
patient with advanced heart failure
we included the patients with advanced heart failure who had the poor cardiac function(LVEF<=30%) and was admitted to the general ward or emergency room within one year.
- advanced care management [ Time Frame: 3 months for each interval and 4 times on each patient (total 9 months on this study) ]we use a modified questionnaire "assessment the medical needs and preference on terminal patients and their families (Tang, et al., 2004) by literature review and named "The prognosis and message status on patients with advanced Heart failure. the questionnaire include 3 parts: medical preference in their advanced status, communication between physician and patients and physician and their families ( the definition of families in this study is the major medical decision for the patients), and the knowledge of disease prognosis. The questionnaire include 17 items with continue and category variables. Before study we use expert validity from 5 experts who works in group at least 10 years. Each items is scored on a five-point Likert scale range from 0(not at all) to 4 (very appropriate to this study). The overall score was calculated as the average of all items and finally we got 3.67-points.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03526627
|Contact: Kai-di Kaofirstname.lastname@example.org|
|Contact: Shiu-yu Chiu, PhD||886-2-2822-7101 ext email@example.com|
|National Taiwan University Hospital||Recruiting|
|Taipei, Zhongzheng, Taiwan, 100|
|Contact: Kai-di Kao 886-928846909 firstname.lastname@example.org|
|Contact: Shiu-yu Chiu 886-2-2822-7101 ext 3316 email@example.com|
|Principal Investigator:||Kai-di Kao||National Taiwan University Hospital|